Page last updated: 2024-08-23

etoposide and Acute Lymphoid Leukemia

etoposide has been researched along with Acute Lymphoid Leukemia in 288 studies

Research

Studies (288)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (1.04)	18.7374
1990's	122 (42.36)	18.2507
2000's	101 (35.07)	29.6817
2010's	48 (16.67)	24.3611
2020's	14 (4.86)	2.80

Authors

Authors	Studies
Bateman, CM; Chi, YY; Cooper, TM; Gaynon, PS; Hutchinson, RJ; Laetsch, TW; Loftus, JP; Malvar, J; Orgel, E; Rheingold, SR; Schafer, ES; Schultz, KR; Silverman, LB; Sposto, R; Sulis, ML; Tasian, SK; Wayne, AS; Whitlock, JA	1
Arai, Y; Ashida, T; Atsuta, Y; Doki, N; Eto, T; Fukuda, T; Harada, K; Ichinohe, T; Kako, S; Kanda, J; Kanda, Y; Maruyama, Y; Morita-Fujita, M; Onizuka, M; Ozawa, Y; Takada, S; Toyosaki, M; Uchida, N	1
Béné, MC; Chevallier, P; Eveillard, M; Garnier, A; Guillaume, T; Jullien, M; Le Bourgeois, A; Peterlin, P; Seguin, A	1
Bojalil-Álvarez, L; Cortés, JE; Fernández-Gutiérrez, JA; García-Villaseñor, E; Murrieta-Álvarez, I; Reyes-Cisneros, OA; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Sánchez-Bonilla, D	1
Becker, PS; Cassaday, RD; Cooper, JP; Estey, EH; Fang, M; Garcia, KA; Halpern, AB; Hendrie, PC; Liu, YJ; Martino, CH; Oehler, VG; Orozco, JJ; Percival, MM; Radich, JP; Sala-Torra, O; Shustov, AR; Soma, LA; Stevenson, PA; Walter, RB; Zarling, LC	1
Gan, X; Li, J; Peng, T; Wang, Y; Zhang, L	1
Imamura, M	1
Boddy, AV; Haber, M; Langenhorst, J; Lau, L; Lock, RB; Marshall, GM; Punt, AM; Sia, KCS; Span, M; Sutton, R; Trahair, T; Tyrrell, V; van Maarseveen, E; Venn, N; Xie, J	1
García-Hernández, MH; Godina-González, S; Medina-Rosales, MN	1
Dykes, J; Håkansson, Y; Król, L; Pronk, C; Toporski, J; Turkiewicz, D	1
Abdelhafiz, A; Elfishawi, S; Gameel, A; Ibraheem, D; Kamel, A; Madney, Y; Osman, R; Radwan, E; Rasekh, EO	1
Aleinikova, O; Ansari, M; Ariffin, H; Bader, P; Balduzzi, A; Bierings, M; Buechner, J; Burkhardt, B; Corbacioglu, S; Dalle, JH; Diaz-de-Heredia, C; Essa, M; Güngör, T; Ifversen, M; Lankester, A; Locatelli, F; Meisel, R; Peters, C; Pichler, H; Poetschger, U; Schrappe, M; Schultz, K; Sedlacek, P; Shaw, PJ; Staciuk, R; Stein, J; Svec, P; Toporski, J; Truong, TH; Vettenranta, K; von Stackelberg, A	1
Bas, EG; Celen, S; Daloglu, H; Hazar, V; Kabakci, C; Karasu, GT; Pashayev, D; Pehlivan, B; Uygun, V; Yalcin, K; Yesilipek, A; Zhumatayev, S	1
Aotsuka, N; Doki, N; Fujisawa, S; Fujiwara, SI; Gotoh, M; Ishizaki, T; Kanamori, H; Kanda, J; Kanda, Y; Kimura, SI; Miyazaki, T; Mori, T; Najima, Y; Okamoto, S; Onizuka, M; Saito, T; Sakaida, E; Shono, K; Tachibana, T; Takahashi, S; Tanaka, M; Watanabe, R	1
Absalon, MJ; Ahmed, A; August, K; Baker, SD; Boklan, J; Brown, PA; Cooper, TM; Gore, L; Li, L; Macy, ME; Magoon, D; Narendran, A; Pollard, J; Sison, EAR; Trippett, T	1
Bennekou, SH; Hernandez, AF; Menendez, P; Pelkonen, O; Terron, A	1
Chastagner, P; Clément, L; Clerc-Urmès, I; Cordero, C; Loboda, C; Pochon, C	1
Aljurf, M; Apperley, J; Bloor, A; Chaganti, S; Czyz, A; Finke, J; Giebel, S; Labopin, M; Michallet, M; Mohty, M; Murray, M; Nagler, A; Orchard, K; Passweg, J; Reményi, P; Socié, G; Stuhler, G; Volin, L; Yakoub-Agha, I	1
Li, TT; Ma, JJ; Tao, SD; Yu, L; Zhang, L	1
Brown, PA; Chen, Y; Devidas, M; Esiashvili, N; Followill, DS; Grupp, SA; Hunger, SP; Kalapurakal, JA; Kessel, S; Laurie, F; Lu, X; Merchant, TE; Pulsipher, MA; Sathiaseelan, V; Schmitter, MK; Ulin, K; Wall, DA	1
Ahmad, A; Banerjee, S; Berney, DM; Graham, R; Hockings, H; Ledermann, J; Liberale, V; Lockley, M; Murali, K; Newton, C; Sarker, SJ; Shamash, J; Stoneham, S	1
Aleksandrova, LN; Bezborodova, OA; Iakubovskaia, RI; Kovalenko, AL; Nemtsova, ER; Venediktova, IuB	1
Chang, WJ; Kim, SJ; Kim, WS; Ko, YH	1
Burke, MJ; Gorman, MF; Gossai, N; Karras, NA; Patel, NJ; Verneris, MR	1
Forman, SJ; Kim, JH; Liu, A; Palmer, J; Rosenthal, J; Schultheiss, TE; Stein, A; Tsai, N; Wong, JY	1
Ahn, JS; Chung, JS; Jo, DY; Joo, YD; Jung, SH; Kim, DY; Kim, I; Lee, JJ; Lee, KH; Moon, JH; Park, S; Shin, HJ; Sohn, SK; Song, IC; Yang, DH	1
Ahn, HS; Jang, IJ; Jang, MK; Kang, HJ; Kim, H; Kim, NH; Kim, S; Lee, JW; Lee, SH; Park, JD; Park, KD; Shin, HY; Song, SH; Yu, KS	1
Berube, C; Coutré, SE; Dinner, S; Dunn, T; Gotlib, J; Liedtke, M; Medeiros, B; Patel, S	1
Aoki, T; Arakawa, Y; Hanada, R; Hayashi, M; Koh, K; Kubota, Y; Mori, M; Oyama, R	1
Albert, MH; Bader, P; Ebell, W; Ehlert, K; Gruhn, B; Gungor, T; Holter, W; Klingebiel, T; Kremens, B; Lang, P; Matthes-Martin, S; Meisel, R; Peters, C; Poetschger, U; Schrappe, M; Schrauder, A; Schrum, J; Schulz, A; Strahm, B; Sykora, KW; von Stackelberg, A; Woessmann, W; Zimmermann, M	1
Chrzanowska, M; Kazimierczak, U; Kowalczyk, DW; Sobiak, J; Styczyński, J; Szpecht, D; Wachowiak, J; Wysocki, M	1
Banerjee, S; Bhattacharyya, M; Chakrabarti, S; Jain, CK; Majumder, HK; Majumder, SS; Mondal, NB; Pradhan, BS; Roychoudhury, S	1
Bae, SH; Chi, HS; Eom, HS; Hyun, MS; Jang, DY; Joo, YD; Jung, CW; Kim, DY; Kim, H; Kim, HJ; Kim, I; Kim, MK; Lee, GW; Lee, JH; Lee, KH; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Park, S; Ryoo, HM; Shin, HJ; Sohn, SK; Won, JH; Yang, DH; Yun, SC	1
Arnold, R; Ayuk, F; Beelen, D; Bethge, W; Bornhäuser, M; Gökbuget, N; Heinzelmann, M; Hölzer, D; Kobbe, G; Kröger, N; Martin, H; Meyer, RG; Pichlmeier, U; Schmid, C; Stelljes, M; Trenschel, R; Wolschke, C; Zander, A	1
Baruchel, A; Bertrand, Y; Brethon, B; Cave, H; Galambrun, C; Gandemer, V; Leverger, G; Nelken, B; Plat, G; Rohrlich, P; Schmitt, C; Thomas, C; Vérité, C	1
DiPersio, JF; Fletcher, TR; Hsu, YM; Link, DC; Schmidt, AP; Stock, W; Trinkaus, KM; Uy, GL; Westervelt, P	1
Chiang, AK; Ha, SY; Lee, V; Li, CK; Liu, AP	1
Gao, J; Guo, J; Guo, X; Jia, CS; Li, Q; Zhou, CY; Zhu, YP	1
Ashizawa, M; Fujiwara, S; Hatano, K; Ito, S; Kanda, Y; Kawasaki, Y; Mashima, K; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R	1
Bursen, A; Castaño, J; González, F; Gutiérrez, NC; Herrero, AB; Marschalek, R; Menendez, P	1
Rosen, D; Sinno, MG; Wittler, R	1
Chrzanowska, M; Danielak, D; Główka, F; Sobiak, J; Wachowiak, J	1
Bleibel, WK; Bogni, A; Cai, X; Cheng, C; Dolan, ME; Fan, Y; Liu, W; Pei, D; Pui, CH; Relling, MV; Rocha, JC; Yang, J; Yang, W	1
Alvarnas, JC; Blume, KG; Cherry, AM; Forman, SJ; Laport, GG; Negrin, RS; Palmer, JM; Slovak, ML; Snyder, DS; Wong, RM	1
Gottlieb, AB; Seidler, AM	1
Abe, A; Hayasaka, K; Kawakami, K; Kawano, Y; Kumamoto, T; Nishikawa, T; Okamoto, Y; Tonooka, S	1
Barnich, M; Cairo, M; Chang, M; Griffin, TC; Gross, TG; Hutchison, R; Shiramizu, B; Weinstein, H; Weitzman, S; Wiley, J; Woods, D	1
Karanjeet, KB; Kurinna, SM; Martelli, AM; McCubrey, JA; Ruvolo, PP; Ruvolo, VR; Schuster, TF	1
Brassesco, MS; Camparoto, ML; Gras, DE; Martinez-Rossi, NM; Montaldi, AP; Sakamoto-Hojo, ET; Scrideli, CA; Tone, LG	1
Borowitz, MJ; Bowman, WP; Camitta, BM; Campana, D; Cao, X; Carroll, WL; Cheng, C; Davies, SM; Devidas, M; Downing, JR; Evans, WE; Fan, Y; French, D; Hunger, SP; Neale, G; Pei, D; Pounds, SB; Pui, CH; Relling, MV; Treviño, LR; Willman, CL; Yang, JJ; Yang, W	1
Behm, FG; Campana, D; Hijiya, N; Hudson, MM; Onciu, M; Pui, CH; Razzouk, BI; Ribeiro, RC; Sandlund, JT; Zhou, Y	1
Li, Y; Mi, Y; Qiu, L; Wang, J; Zhao, Y; Zou, D	1
Guo, W; Ji, Z; McHale, CM; Smith, MT; Zhang, L	1
Bargetzi, M; Dudler, C; Gratwohl, A; Passweg, JR; Tichelli, A; Wernli, M	1
Abichandani, R; Barry, E; Carroll, WL; Chu, R; Cooper, T; Gaynon, P; Hijiya, N; Jeha, S; Kadota, R; Rytting, M; Shen, V; Silverman, L; Steinherz, P; Thomson, B	1
Barberi, W; Bernardo, ME; Bertaina, A; Giraldi, E; Locatelli, F; Merli, P; Parasole, R; Pession, A; Rizzari, C; Testi, AM; Zecca, M	1
Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P	1
Ishii, E	1
Arceci, RJ; Bernstein, M; Buck, S; Chang, MN; Dahl, GV; Kshirsagar, S; Lacayo, NJ; Lum, BL; O'Brien, MM; Ravindranath, Y; Sikic, BI; Weinstein, H	1
Ebell, W; Escherich, G; Fengler, R; Henze, G; Karachunsky, A; Kaspers, G; Klingebiel, T; Mann, G; Niggli, F; Ratei, R; Schrappe, M; Tallen, G; von Stackelberg, A	1
Li, R; Tu, P; Wang, X; Yang, S	1
Ancliff, P; Darbyshire, P; Goulden, N; Green, N; Hancock, J; Leighton, C; Love, S; Masurekar, A; Moorman, AV; Morgan, M; Parker, C; Révész, T; Saha, V; Sutton, R; Waters, R	1
Bueno, C; Catalina, P; Menendez, P; Montes, R; Rodríguez, R	1
Chrzanowska, M; Grund, G; Sobiak, J; Wachowiak, J	1
Barry, E; Borowitz, MJ; Carroll, WL; Cooper, T; Dahl, G; Gaynon, PS; Hijiya, N; Isakoff, MS; Jeha, S; Kadota, R; Maloney, K; Paul, JA; Shen, V; Silverman, LB; Steinherz, PG; Thomson, B; Thottassery, JV	1
Atsuta, Y; Fukuda, T; Fukuhara, T; Imamura, M; Ito, YM; Iwato, K; Kanamori, H; Kawase, T; Kobayashi, N; Kumano, K; Morishima, Y; Shigematsu, A; Suzuki, R; Tanaka, J; Yamashita, T; Yoshiba, F	1
Aguilar-Lemarroy, A; Barrera-Chaires, E; Bravo-Cuellar, A; de Celis, R; González-Ramella, Ó; Gurrola-Díaz, C; Hernández-Flores, G; Jave-Suárez, LF; Lerma-Díaz, JM; Ortiz-Lazareno, PC; Rosales-Aviña, JA; Torres-Flores, J	1
Barisone, E; Bertorello, N; Calvillo, M; De Rossi, G; Dufour, C; Lo Nigro, L; Luciani, M; Messina, C; Miano, M; Micalizzi, C; Parasole, R; Petruzziello, F; Pistorio, A; Putti, MC; Varotto, S; Ziino, O	1
Arceci, RJ; Barry, E; Hijiya, N	1
Barba, P; Bueno, J; Calbacho, M; Fernández, P; García-Boyero, R; Gonzalez, J; Martínez-Sánchez, P; Ribera, JM; Sampol, A; Serrano, J	1
Degnan, AJ; Levy, LM	1
Forman, S; Liu, A; Palmer, J; Radany, E; Rosenthal, J; Schultheiss, T; Somlo, G; Stein, A; Wong, JY	1
Bozkurt, C; Dogru, M; Kocaoglu, AC; Ozmen, S	1
Abella, E; Amigo, ML; Barrios, M; Bravo, P; Brunet, S; García, O; González-Campos, J; Hernández-Rivas, JM; Montesinos, P; Ribera, JM	1
Borst, J; Rooswinkel, RW; van de Kooij, B; Verheij, M	1
Pogorzała, M; Styczyński, J; Szczepanek, J; Tretyn, A; Wysocki, M	1
Ahmed, AB; Bruserud, O; Hatfield, KJ; Kittang, AO; Reikvam, H; Sjo, M; Tvedt, TH	1
Czyzewski, K; Debski, R; Jaworska-Posadzy, A; Kolodziej, B; Kubicka, M; Kurylo-Rafinska, B; Piatkowska, M; Pogorzala, M; Styczynski, J; Wysocki, M	1
Handa, H; Isozumi, K; Komatsumoto, S; Motohashi, S; Nara, M	1
Andersson, PO; Brune, M; Gustavsson, B; Stockelberg, D; Wadenvik, H; Wernstedt, P	1
Berger, SJ; Cooper, BW; Donaher, E; Gerson, SL; Gosky, DM; Green, SB; Hoppel, CL; Ingalls, ST; Lazarus, HM; Li, X; Rosenthal, NS	1
Crocci, AJ; Lopes, LF; Minicucci, EM	1
Behm, FG; Blanco, JG; Boyett, JM; Evans, WE; Kun, LE; Pui, CH; Raimondi, S; Relling, MV; Rivera, GK; Sandlund, JT	1
Beck, JD; Borkhardt, A; Creutzig, U; Harbott, J; Jacobs, U; Langer, T; Leis, T; Metzler, M; Rascher, W; Reichel, M; Reinhardt, D; Repp, R; Ritter, J; Schrappe, M; Stanulla, M; Viehmann, S	1
Boyett, JM; Edick, MJ; Gajjar, A; Harrison, PL; Mahmoud, HH; Panetta, JC; Pui, CH; Relling, MV; Ribeiro, RC; Rivera, GK; Sandlund, JT; van de Poll, ME	1
Corbacioglu, S; Eber, S; Gungor, T; Hummerjohann, J; Niggli, F	1
Cetin, M; Yetgin, S	1
Takeuchi, M; Yoshida, I	1
Boureau, B; Chen, P; Cook, EH; Das, S; Kishi, S; Morand, S; Pui, CH; Relling, MV; Rosner, GL; Schuetz, E; Yang, W	1
Debatin, KM; Eckhoff, S; Meyer, LH; Mohr, A; Stahnke, K	1
Amylon, MD; Blume, KG; Jamieson, CH; Wong, RM	1
Andreeff, M; Carlson-Bremer, D; Jiffar, T; Konopleva, M; Kurinna, S; Ricciardi, MR; Ruvolo, PP; Suck, G	1
Boiron, JM; Buzyn, A; Delannoy, A; Fegueux, N; Fière, D; Gardin, C; Georges, M; Hacini, M; Huguet, F; Kuentz, M; Lhéritier, V; Micléa, JM; Reman, O; Stamatoullas, A; Thomas, X; Vernant, JP	1
Ault, K; Case, D; Damon, LE; Johnston, LJ; Linker, CA; Ries, CA; Rugo, HS	1
Fortney, JE; Gibson, LF; Wang, L	1
Abe, T; Aizawa, Y; Furukawa, T; Fuse, I; Hashimoto, S; Kishi, K; Koike, T; Kuroha, T; Masuko, M; Sato, N; Takahashi, H; Yano, T	1
Forestier, E; Frost, BM; Gustafsson, G; Hellebostad, M; Jonsson, OG; Kanerva, J; Larsson, R; Lönnerholm, G; Nygren, P; Schmiegelow, K	1
Behm, FG; Campana, D; Cheng, C; Downing, JR; Evans, WE; Howard, SC; Hudson, MM; Kun, LE; Pei, D; Pui, CH; Raimondi, SC; Razzouk, BI; Relling, MV; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT	1
Behm, FG; Cheng, C; Gajjar, A; Hijiya, N; Jeha, S; Liu, W; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; Zhang, Z	1
Annunziata, M; Copia, C; D'Amico, MR; De Simone, M; Ferrara, F; Mele, G; Palmieri, S; Pocali, B; Schiavone, EM; Viola, A	1
Avramis, V; Douglas, JG; Felgenhauer, J; Geyer, JR; Hawkins, DS; Holcenberg, J; Loken, MR; Meshinchi, S; Park, JR; Thomson, B	1
Kluin, PM; Kluin-Nelemans, HC; Kramer, MH; MacKenzie, MA; Meulendijks, LA; Ossenkoppele, GJ; Raemaekers, JM; Schouten, HC; Sonneveld, P; van 't Veer, MB; van der Holt, B; van Imhoff, GW; van Marwijk Kooy, M; van Oers, MH; Verdonck, LF; Wijermans, PW	1
Chi, HS; Choi, SJ; Jang, S; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Park, CJ; Ryu, SG; Seol, M	1
Buck, S; Ido, M; Inaba, H; Kaplan, J; Komada, Y; Shimada, K; Yonehara, S; Zhou, YW	1
Ahn, BM; Baek, JH; Jeon, SB; Kim, DH; Kim, JG; Lee, KB; Moon, JH; Sohn, SK; Sung, WJ	1
Campana, D; Cheng, C; Downing, JR; Evans, WE; Hijiya, N; Howard, SC; Hudson, M; Jeha, S; Pei, D; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT	1
Hayashi, Y; Kanazawa, T; Morikawa, A; Ogawa, C; Taketani, T; Taki, T	1
Bosq, J; Casassus, P; Diviné, M; Dupriez, B; Koscielny, S; Le Maignan, C; Pico, JL; Raphaël, M; Ribrag, V; Sebban, C; Stamattoulas, A	1
Escherich, G; Hassenpflug, WA; Horstmann, MA; Janka, G; Kabisch, H; zur Stadt, U	1
Goldstone, A; Hann, I; Mitchell, C; Ramanujachar, R; Richards, S; Rowe, J; Vora, A; Webb, D	1
Blume, KG; Cairo, MS; Copelan, EA; Forman, SJ; Gale, RP; Horan, JT; Horowitz, MM; Keating, A; Lazarus, HM; Litzow, MR; Marks, DI; McCarthy, PL; Pérez, WS; Schultz, KR; Smith, DD; Trigg, ME; Weisdorf, DJ; Zhang, MJ	1
Couturier, J; de Cremoux, P; Delattre, O; Doz, F; Fehlbaum, P; Jourdan-Da-Silva, N; Klijanienko, J; Michon, J; Mosseri, V; Schleiermacher, G; Tran-Perennou, C; Vielh, P	1
Bohlius, J; Engert, A; Hülsewede, H; Kober, T	1
Bernbeck, B; Dilloo, D; Huck, K; Laws, HJ; Meisel, R; Pape, H; Schonberger, S; Stackelberg, VA; Traeger, A	1
Belevtsev, MV; Buglova, SE; Shman, TV	1
Salonen, JH	1
Alonso Ojembarrena, A; Contra Gómez, T; Díaz Pérez, MA; García Castro, J; González-Vicent, M; Madero López, L; Pérez Martínez, A; Ramírez Orellana, M	1
Britt-Marie, F; Eva, L; Frost, BM; Göran, G; Gudmar, L; Gustafsson, G; Hellebostad, M; Jukka, K; Kanerva, J; Kjeld, S; Liliemark, E; Lönnerholm, G; Marit, H; Palle, J; Schmiegelow, K	1
Doyle, JJ; Gassas, A; Saunders, EF; Sung, L	1
Brownstein, C; Carroll, WL; Horton, TM; Lee, H; Min, DJ; Moskowitz, NP	1
Clarke, LE; Goldfeder, KL; James, WD; Katz, KA; Levin, JM; Loren, AW	1
Marks, DI	1
Daenen, S; de Wolf, JT; Kluin-Nelemans, HC; van den Berg-de Ruiter, E; van Imhoff, GW; Vellenga, E	1
Aikawa, K; Arima, F; Fukuda, H; Hanada, S; Hotta, T; Kasai, M; Kobayashi, T; Masanori, S; Mukai, K; Ogura, M; Shirakawa, S; Sueoka, E; Tajima, K; Takeyama, K; Tobinai, K	1
Al-Ejeh, F; Brown, MP; Darby, JM; Diener, KR; Hayball, JD; Pensa, K	1
Akay, OM; Gulbas, Z; Oner, U; Urer, SM	1
Asaka, M; Endo, T; Hashino, S; Imamura, M; Kahata, K; Koike, T; Kondo, T; Nishio, M; Obara, M; Onozawa, M; Ota, S; Shigematsu, A; Shiratori, S; Sugita, J; Takahata, M; Takeda, Y; Tanaka, J; Wakasa, K; Yamamoto, S	1
Advani, SH; Badrinath, Y; Bajpai, S; Gladstone, B; Kapoor, G; Nair, CN	1
Chang, J; Crowther, D; Morgenstern, GR; Pettengell, R; Radford, JA; Rowlands, M; Scarffe, JH; Testa, NG; Woll, PJ; Young, R	1
Bar Ziv, J; Or, R; Polliack, A; Safadi, R	1
Ariyama, Y; Fujii, H; Nakagawa, H; Sonoda, Y	1
Dommann-Scherrer, C; Honegger, HP; Jacky, E; Jost, LM; Maurer, R; Sauter, C; Stahel, RA	1
Behm, FG; Boyett, JM; Hancock, ML; Krance, RA; Mahmoud, HH; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Sandlund, JT	1
Gastineau, DA; Hoagland, HC; Letendre, L; Noel, P; Solberg, LA; Tefferi, A	1
Crowther, D; Ghielmini, M; Morgenstern, GR; Pettengell, R; Radford, JA; Scheid, C; Stern, PL	1
Andersson, B; Dimopoulos, M; Giralt, S; Khouri, I; Mehra, R; Przepiorka, D; Rodriguez, M; Suki, S; Tabocoff, J; van Besien, K	1
Aster, JC; Inhorn, RC; Roach, SA; Slapak, CA; Soiffer, R; Stone, RM; Tantravahi, R	1
Abe, T; Hirao, A; Kawano, Y; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y; Watanabe, T	1
Fujii, H; Kuzuyama, Y; Maekawa, T; Nakagawa, H; Sonoda, Y	1
Wu, GQ	1
Greco, FA; Greer, JP; Hainsworth, JD; Waits, TM	1
Boer, R; Ferry, DR; Gekeler, V; Ise, W; Kerr, DJ; Malkhandi, J	1
Cowie, FJ; Dick, G; Flanagan, RJ; Judson, I; McCarthy, PT; Phillips, M; Pinkerton, CR	1
Chavez, CM; Duncan, MH; Holdsworth, MT; Leasure, MM; Raisch, DW	1
Crooks, GM; Sato, JK	1
Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ	1
Bolaños, F; Candelaria, M; Hurtado, R; Labardini, JR; Majluf, A; Vargas, F	1
Brown, GA; Deuchars, KL; Freedman, MH; Goldenberg, GJ; Gu, L; Hedley, DW; McPherson, JP; Toso, R	1
Berger, R; Bernard, O; Derré, J; Flexor, M; Hillion, J; Jonveaux, P; Larsen, CJ; Le Coniat, M	1
Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW	1
den Ottolander, GJ; Falkenburg, JH; Fibbe, WE; Kluin-Nelemans, JC; Starrenburg, CW; van der Burgh, JF; Willemze, R; Zijlmans, JM	1
Anasetti, C; Bensinger, WI; Buckner, CD; Clift, RA; Demirer, T; Lilleby, K; Martin, P; Petersen, FB; Sanders, J; Weaver, CH	1
Ashihara, E; Fujita, N; Goto, H; Hirata, T; Inaba, T; Nakagawa, M; Okawa, K; Oku, N; Shimazaki, C; Yamagata, N	1
Bélanger, R; Boileau, J; Bonny, Y; Gyger, M; Kassis, J; Lacombe, M; Lavallée, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A	1
Abe, T; Hirao, A; Kawahito, M; Kawano, Y; Makimoto, A; Saito, S; Sato, J; Suzue, T; Takaue, Y; Watanabe, T	1
Chan, KW; Cole, CH; Davis, JE; Phillips, G; Pritchard, S; Rogers, PC	1
Vogler, WR	1
Bailey, CC; Chessells, JM; Eden, OB; Lilleyman, JS; Richards, SM	1
Ito, H; Kimura, Y; Nakamura, H; Nomura, N; Otaka, M; Sakai, N; Shirota, T; Suzuki, A; Toyama, K; Uchida, H	1
Kobayashi, K; Ratain, MJ	1
Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM	1
Baumgarten, E; Besserer, A; Henze, G; Scheffler, A; Schmid, H; Schwerdtfeger, R; Serke, S; Siegert, W; Zingsem, J	1
D'Angio, GJ	1
Aricò, M; Egeler, RM; Favara, BE; Heitger, A; Neglia, JP; Nesbit, ME	1
Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Schmidt, GM; Snyder, DS; Stein, AS; Taguchi, J	1
Adachi, S; Akiyama, Y; Hirota, H; Kubota, M; Kuwakado, K; Matsubara, K; Mikawa, H; Wakazono, Y	1
Anasetti, C; Appelbaum, FR; Bensinger, W; Bianco, J; Clift, R; Martin, P; Petersen, FB; Press, O; Singer, J; Weaver, CH	1
Bowman, WP; Croce, CM; Felix, CA; Lange, BJ; Negrini, M; Winick, NJ	1
Bell, B; Bernstein, ML; Buchanan, GR; Devine, S; Dreyer, Z; Grier, H; Krischer, J; Kung, F; Land, V; Whitehead, VM	1
Gajewski, J; Lee, M; Nimer, S; Schiller, G; Territo, M	1
Davidson, NE; Desnoyers, S; Kaufmann, SH; Ottaviano, Y; Poirier, GG	1
Bailey, CC; Curzon, ME; Duggal, MS; Hart, P; O'Sullivan, EA	1
Kuroume, T; Shitara, T; Sotomatsu, M; Yugami, S	1
Aherne, GW; Dick, G; Pinkerton, CR	1
Cole, M; Lowis, SP; Newell, DR; Pearson, AD	1
Carter, C; Hodges, S; Lee, EJ; Reck, K; Schiffer, CA	1
Borowitz, MJ; Bowman, WP; Buchanan, GR; Jacaruso, D; Kamen, BA; McKenna, RW; Schneider, NR; Shuster, JJ; Winick, NJ	1
Bettoni, C; Daszkiewicz, P; Ebell, W; Głuszak, B; Kaczmarek-Kanold, M; Lange, A; Malicki, J; Suchnicki, K; Wachowiak, J	1
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K	1
Crist, WM; Evans, WE; Mahmoud, HH; Pui, CH; Relling, MV; Ribeiro, RC; Rivera, GK; Sandlund, JT	1
Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA	1
Bradstock, K; Brisco, J; Enno, A; Hughes, E; McCaul, K; Morley, AA; Neoh, SH; Sykes, PJ; Szer, J	1
Grander, D; Heyman, M; Jeddi-Tehrani, M; Johansson, B; Liu, Y; Nordgren, A; Ost, A; Rasool, O; Wallberg, B	1
Beretta, F; Cavalli, F; Ghielmini, M; Marini, G; Sanna, P	1
Canpynar, H; Cetin, M; Hiçsönmez, G; Kansu, E; Tuncer, AM	1
Björkholm, M; Gruber, A; Liliemark, E; Liliemark, J; Osby, E; Peterson, C; Sirzea, F; Söderhäll, S; Zhou, R	1
Nishikawa, K	1
Borowitz, M; Bowman, WP; Buchanan, GR; Farrow, A; Jacaruso, D; Kamen, BA; Shuster, JJ; Winick, N	1
Cattan, AR; Douglas, EA; Levett, D; Middleton, PG; Taylor, PR	1
Chubachi, A; Hashimoto, K; Hayashi, Y; Miura, AB; Miura, I; Nimura, T; Ohshima, A; Seto, M; Takahashi, N; Ueda, R; Utsumi, S	1
Cooper, DL; Levy, A; Salloum, E; Tallini, G	1
Catapano, CV; Fernandes, DJ; Qiu, J	1
Akatsuka, J; Fujisawa, K; Hoshi, Y; Hurusato, M; Kobayashi, H; Maekawa, K; Uchiyama, H; Urashima, M	1
Burke, PJ; Gore, SD; Karp, JE; Kaufmann, SH	1
Flexner, JM; Goodman, S; Greer, JP; Stein, RS; Wolff, SN	1
Dekker, AW; Haak, HL; Huijgens, PC; Löwenberg, B; Ossenkoppele, G; Schouten, HC; Sizoo, W; Sonneveld, P; van der Lelie, J; van Putten, WL; van't Veer, MB; Verdonck, LF; Willemze, R	1
Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S	1
Bayle, C; Carde, P; Macintyre, E; Nasr, F; Ribrag, V; Venuat, AM	1
Brøndum-Nielsen, K; Johansson, B; Karle, H; Pedersen-Bjergaard, J	1
Lennard, L; Lilleyman, JS; Welch, JC	1
Azuma, E; Higashigawa, M; Hirayama, M; Hori, H; Ido, M; Kawasaki, H; Sakurai, M	1
Carriço, MK; Coelho, AM; Klumb, CE; Maia, RC; Noronha, H; Ruimanek, VM; Vasconcelos, FC	1
April, F; Meneghini, V; Perona, G; Pizzolo, G; Ricetti, MM; Solero, P; Tecchio, C; Todeschini, G; Veneri, D; Zanotti, R	1
Behm, FG; Boyett, JM; Evans, WE; Nemec, J; Pui, CH; Relling, MV; Yanishevski, Y	1
Goi, K; Iijima, K; Inukai, T; Kagami, K; Kinoshita, A; Kojika, S; Mori, T; Nakazawa, S; O-Koyama, T; Sugita, K; Suzuki, T; Tezuka, T	1
Asai, O; Dobashi, N; Kato, A; Katori, M; Kobayashi, T; Kuraishi, Y; Nagamine, M; Tajima, N; Usui, N; Watanabe, H; Yamazaki, H; Yano, S	1
Apel, D; Maj, S; Mariańska, B; Seferyńska, I	1
Bailey, C; Burrett, J; Chessells, J; Hann, I; Hill, F; Richards, S	1
Fuscoe, JC; Hanley, NM; Knapp, GW; Pui, CH; Relling, MV; Sandlund, JT; Setzer, RW	1
Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T	1
Bogusławska-Jaworska, J; Gorczyńska, E; Słociak, M; Toporski, J	1
Haut, P; Kletzel, M; Marymount, M; Morgan, E; Pirich, L	1
Camera, A; Catalano, L; Picardi, M; Rotoli, B; Selleri, C	1
Chin, M; Harada, K; Imashuku, S; Mugishima, H; Nagata, T; Shichino, H; Suzuki, T; Yamada, A	1
Chimishkian, K; Gurova, K; Litvinova, E; Mentkevich, G	1
Ozbek, N; Tuncer, AM; Yetgin, S	1
Eden, OB; Gibson, B; Hann, I; Hill, F; Kinsey, S; Lilleyman, J; Mitchell, C; Richards, S; Vora, A	1
Auclerc, MF; Auvrignon, A; Baruchel, A; Bauduer, F; Berthou, C; Bordigoni, P; Demeocq, F; Lamagnere, JP; Landman-Parker, J; Leblanc, T; Legall, E; Leverger, G; Mathey, C; Michel, G; Pautard, B; Perel, Y; Schaison, G; Schneider, P	1
Belasco, JB; Bunin, NJ; Lange, BJ; Leahey, AM; Meek, R; Scher, C	1
Frost, BM; Gustafsson, G; Larsson, R; Lönnerholm, G; Nygren, P	1
Hamahata, K; Kubota, M; Lin, Y; Usami, I; Watanabe, K	1
Estlin, EJ; Hall, AG; Lowis, SP	1
Ciocca, ME; De Dávila, MT; Felice, MS; Fraquelli, LE; Hammermuller, E; Lorusso, AM; Sackmann-Muriel, F	1
Behm, FG; Boyett, JM; Campana, D; Coustan-Smith, E; Hancock, ML; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sancho, J; Sandlund, JT	1
Huismans, DR; Pieters, R; Schuurhuis, GJ; Styczynski, J; Veerman, AJ; Wysocki, M	1
Balduzzi, A; Biagi, E; De Lorenzo, P; Rovelli, A; Tagliabue, A; Uderzo, C	1
Eguchi, M; Eguchi-Ishimae, M; Ishii, E; Kamada, N; Miyazaki, S; Mizutani, S; Ueda, K	1
Bieri, S; Chapuis, B; Helg, C; Miralbell, R	1
Weiss, M	1
Anderson, JJ; Angus, B; Hall, AG; Horne, CH; Lodge, AJ; McIntosh, GG; Reid, MM; Steward, M	1
Atra, A; Gerrard, M; Hann, IM; Hobson, R; Imeson, JD; Pinkerton, CR	1
Eden, O; Gibson, B; Hann, I; Harrison, C; Harrison, G; Hill, F; Richards, S; Vora, A	1
Auperin, A; Behrendt, H; Coze, C; Frappaz, D; Leverger, G; Lutz, P; Michon, J; Patte, C; Perel, Y; Raphaël, M; Terrier-Lacombe, MJ	1
Kanda, Y; Mineishi, S; Murakami, J; Ogasawara, T; Saito, T; Seo, S; Shoji, N; Takaue, Y; Tanosaki, R; Tobinai, K	1
Fletcher, BD; Harrison, PL; Kaste, SC; Kennedy, W; Neel, MD; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT	1
Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A	1
Ahmed, T; Feldman, EJ; Kancherla, R; Liu, D; Papageorgio, C; Pozzuoli, M; Seiter, K; Sreekantaiah, C; Weisberger, J; Weiss, M	1
Flynn, PM; Harrison, PL; Hughes, W; Relling, MV; Schuetz, EG; van de Poll, ME	1
Akiyoshi, K; Ayukawa, H; Eguchi, H; Ishii, E; Kamizono, J; Kawakami, K; Kinukawa, N; Koga, H; Kuroda, H; Matsuzaki, A; Okamura, J; Tamai, Y; Yanai, F	1
Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N	1
Fortney, JE; Gibson, LF; Wenger, SL; Zhao, W	1
Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA	1
Chen, CL; Eddy, L; Rawwas, J; Sorrell, A; Uckun, FM	1
Creutzig, U; de Vries, E; Hählen, K; Huismans, DR; Janka-Schaub, GE; Jansen, G; Kaspers, GJ; Peters, GJ; Pieters, R; Rots, MG; van Zantwijk, CH; Veerman, AJ; Zwaan, CM	1
Chao, TY; Chen, YC; Ho, CL; Hwang, JM; Kao, WY; Sheu, LF	1
Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M	1
Bruggers, CS; Carroll, WL; Liu, T; Moos, PJ; Perkins, SL; Raetz, E; Smith, F	1
Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R	1
Advani, SH; Banavali, SD; Bhatia, KG; Magrath, I; Naresh, KN; Soman, CS	1
Damon, L; Linker, C; Navarro, W; Ries, C	1
Ansoborlo, S; Babin-Boilletot, A; Baruchel, A; Pacquement, H; Patte, C; Plouvier, E; Sakiroglu, C	1
Bokemeyer, C; Fonatsch, C; Freund, M; Rieder, H; Schmoll, HJ	1
Mans, DR; Sonneveld, P; Splinter, TA; van der Gaast, A	1
Crist, WM; Pui, CH; Raimondi, SC	1
Mizoguchi, H; Saito, H	1
Bergerat, JP; Damonte, JC; Dufour, P; Herbrecht, R; Liu, KL; Maloisel, F; Oberling, F; Ortiz, S	1
Cho, J; Slater, LM; Wetzel, M	1
Crist, WM; Crom, WR; Evans, WE; Groom, S; McLeod, HL; Relling, MV; Rivera, GK; Rodman, JH; Silverstein, K	1
Ambros, P; Emminger, W; Emminger-Schmidmeier, W; Ferstl, G; Fink, FM; Haas, OA; Höcker, P; Mann, G; Peters, C; Urban, C	1
Miyachi, H; Ohnuma, T; Sekiguchi, S; Takemura, Y	1
Maca, RD	1
Diedrich, H; Freund, M; Ganser, A; Gramatzki, M; Haas, R; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Kuse, R	1
Bowman, WP; Buchanan, GR; Jacaruso, D; Kamen, BA; Roach, ES; Rollins, N; Winick, NJ	1
Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H	1
Dopfer, R; Ehninger, G; Eichel, B; Proksch, B; Schmidt, H; Waidelich, P	1
Baurmann, H; Henze, G; Kleiner, S; Schmid, H; Schwerdtfeger, R; Siegert, W; Zeiler, T	1
Butturini, A; Gale, RP; Reizenstein, P	1
Ishida, Y; Matusda, H; Tauchi, H; Yokota, Y	1
Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT	1
Brado, B; Haas, R; Ho, AD; Hunstein, W	1
Crist, WM; Crone, ME; Fairclough, DL; Kellie, SJ; Pui, CH; Rivera, GK; Rodman, JH	1
Bostrom, B; Kersey, JH; Kim, T; Ramsay, NK; Weisdorf, DJ	1
Austin, CA; Fisher, LM; Patel, S	1
De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P	1
Björkholm, M	1
Barlogie, B; Dicke, K; Estey, EH; Huh, YO; Kantarjian, HM; Keating, MJ; O'Brien, S; Smith, TL; Spinolo, J; Walters, RS	1
Akiyama, Y; Ito, M; Kamiya, H; Kawa, K; Mikawa, H; Miyazaki, S; Sakurai, M; Tujino, G; Ueda, K	1
Kaneko, Y; Kawai, S; Kondo, M; Mimaya, J; Tonouchi, T; Toyoda, Y; Ueda, R	1
Bennetts, G; Cairo, MS; Sender, L; Toy, C; van de Ven, C	1
Cannon de Rodriguez, W; Chan, KW; Richardson, RO; Rogers, PC; Skala, JP	1
Lee, EJ; Reck, K; Schiffer, CA	1
Colvin, OM; Jones, RJ; Miller, CB; Rowley, SD; Sensenbrenner, LL; Zehnbauer, BA	1
Dicke, KA; Estey, E; Horwitz, LJ; Jagannath, S; Kantarjian, H; Keating, M; McCredie, K; Spinolo, JA; Spitzer, G; Zander, AR	1
Auzanneau, G; Gisselbrecht, C; Gratecos, N; Harousseau, JL; LeBlond, V; Michallet, M; Milpied, N; Sebban, C; Troussard, X; Witz, F	1
Ito, T; Komatsu, M; Saito, Y; Takahashi, H; Toyota, T; Uzuka, Y	1
Bennett, JM; Chang, AY; Rowe, JM	1
Forgeson, G; Gore, M; Goss, G; Lakhani, A; Maitland, J; Milan, S; Nandi, A; Perren, T; Powles, R; Treleaven, J	1
Appelt, M; Leuschner, S; Rister, M; Schaub, J; Schmitz, N; Suttorp, M	1

Reviews

23 review(s) available for etoposide and Acute Lymphoid Leukemia

Article	Year
Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease. Cytotherapy, 2023, Volume: 25, Issue:12 Topics: Adult; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Whole-Body Irradiation	2023
Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research. Archives of toxicology, 2017, Volume: 91, Issue:8 Topics: Adverse Outcome Pathways; Animals; Environmental Exposure; Etoposide; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; Infant; Myeloid-Lymphoid Leukemia Protein; Pesticides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Assessment; Topoisomerase II Inhibitors	2017
Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia. Clinical pharmacology and therapeutics, 2008, Volume: 84, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Case-Control Studies; Child; Child, Preschool; Drug Hypersensitivity; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Reference Values; Risk Assessment	2008
Dermatomyositis induced by drug therapy: a review of case reports. Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:5 Topics: Adult; Aged; Antibodies, Antinuclear; Autoimmune Diseases; Cyclophosphamide; Dermatomyositis; Etoposide; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin	2008
[Progress in the molecular analysis of infant leukemias]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:10 Topics: Enzyme Inhibitors; Etoposide; Female; Gene Rearrangement; Genetic Predisposition to Disease; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myeloid, Acute; Male; Maternal Exposure; MicroRNAs; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Topoisomerase II Inhibitors	2009
Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement. Leukemia, 2011, Volume: 25, Issue:3 Topics: Antigens; Embryonic Stem Cells; Environmental Exposure; Etoposide; Gene Rearrangement; Humans; Infant; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans	2011
Clofarabine in pediatric acute leukemia: current findings and issues. Pediatric blood & cancer, 2012, Volume: 59, Issue:3 Topics: Adenine Nucleotides; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clinical Trials as Topic; Clofarabine; Cyclophosphamide; Cytarabine; Etoposide; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2012
High-dose etoposide in allogeneic stem cell transplantation. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:6 Topics: Adenine Nucleotides; Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Busulfan; Carboplatin; Carmustine; Clinical Trials as Topic; Clofarabine; Cyclophosphamide; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Leukemia; Leukemia, Myeloid, Acute; Lomustine; Mucositis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy, Adjuvant; Severity of Illness Index; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2012
Fourth biannual report of the Cochrane Haematological Malignancies Group. Journal of the National Cancer Institute, 2006, Apr-19, Volume: 98, Issue:8 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Europe; Hematologic Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Multicenter Studies as Topic; Multiple Myeloma; National Institutes of Health (U.S.); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Pyrazines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; United States; Vinblastine; Vincristine	2006
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood, 1995, Apr-01, Volume: 85, Issue:7 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Eosinophilia; Etoposide; Fatal Outcome; Female; Humans; Hydroxyurea; Hyperplasia; Ifosfamide; Leukemia, Myeloid; Lymph Nodes; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Syndrome; Translocation, Genetic; Vincristine	1995
rHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia. Stem cells (Dayton, Ohio), 1995, Volume: 13, Issue:2 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins	1995
Pharmacodynamics and long-term toxicity of etoposide. Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl Topics: Child; Etoposide; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Neoplasms; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testicular Neoplasms	1994
Epipodophyllotoxins in the treatment of childhood cancer. Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide	1994
[Chemotherapy of relapsed AML and ALL]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Recurrence; Remission Induction; Vinblastine	1996
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease. Cancer investigation, 1996, Volume: 14, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Mechlorethamine; Mediastinal Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Spinal Neoplasms; Thoracic Vertebrae; Vinblastine; Vincristine	1996
Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia. British journal of haematology, 2000, Volume: 110, Issue:1 Topics: Antimetabolites, Antineoplastic; Child; Cytarabine; Drug Administration Schedule; Etoposide; Humans; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; Thioguanine	2000
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone. Hematology/oncology clinics of North America, 2001, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine	2001
Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy. Leukemia, 2001, Volume: 15, Issue:6 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cytarabine; Disease Progression; Disease-Free Survival; Enzyme Inhibitors; Etoposide; Female; Humans; Idarubicin; Incidence; Karyotyping; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Neoplasm Proteins; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Topoisomerase II Inhibitors; Treatment Outcome; Tretinoin	2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine	2001
Disposition of antineoplastic agents in the very young child. The British journal of cancer. Supplement, 1992, Volume: 18 Topics: Age Factors; Antineoplastic Agents; Blood Proteins; Child; Child, Preschool; Doxorubicin; Etoposide; Humans; Infant; Infant, Newborn; Liver; Mercaptopurine; Methotrexate; Neoplasms; Nervous System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide	1992
Autotransplants in leukemia: current state, future progress. Leukemia research, 1991, Volume: 15, Issue:9 Topics: Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous; Twins, Monozygotic	1991
Etoposide in acute leukemia. Past experience and future perspectives. Cancer, 1991, Jan-01, Volume: 67, Issue:1 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1991
Etoposide and teniposide in the treatment of acute leukemia. Medical oncology and tumor pharmacotherapy, 1990, Volume: 7, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide	1990

Trials

84 trial(s) available for etoposide and Acute Lymphoid Leukemia

Article	Year
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001). Haematologica, 2022, 10-01, Volume: 107, Issue:10 Topics: Adolescent; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Etoposide; Humans; MTOR Inhibitors; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sirolimus; TOR Serine-Threonine Kinases	2022
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia. Leukemia & lymphoma, 2023, Volume: 64, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Rituximab; Vincristine	2023
The combination of clofarabine, etoposide, and cyclophosphamide shows limited efficacy as a bridge to transplant for children with refractory acute leukemia: results of a monitored prospective study. Pediatric hematology and oncology, 2021, Volume: 38, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Treatment Outcome; Young Adult	2021
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 02-01, Volume: 39, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Chemoradiotherapy; Child; Child, Preschool; Equivalence Trials as Topic; Etoposide; Female; Follow-Up Studies; Humans; International Agencies; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Survival Rate; Thiotepa; Vidarabine; Whole-Body Irradiation	2021
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Co Pediatric blood & cancer, 2017, Volume: 64, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Child; Child, Preschool; Cyclams; Cytarabine; Etoposide; Female; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, CXCR4; Treatment Outcome; Young Adult	2017
Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group. International journal of radiation oncology, biology, physics, 2019, 07-01, Volume: 104, Issue:3 Topics: Adolescent; Analysis of Variance; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Lung; Patient Positioning; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Remission Induction; ROC Curve; Thiotepa; Transplantation Conditioning; Whole-Body Irradiation; Young Adult	2019
Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation. International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Blast Crisis; Bone Marrow; Busulfan; Child; Cyclophosphamide; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphatic Irradiation; Melphalan; Middle Aged; Myelodysplastic Syndromes; Organ Sparing Treatments; Organs at Risk; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Radiotherapy Dosage; Recurrence; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Young Adult	2014
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia. Leukemia research, 2014, Volume: 38, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Salvage Therapy	2014
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-10, Volume: 33, Issue:11 Topics: Adolescent; Child; Child, Preschool; Disease-Free Survival; Etoposide; Europe; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Living Donors; Male; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors; Siblings; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Whole-Body Irradiation	2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology, 2015, Volume: 90, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survival Analysis; Transplantation, Homologous; Vincristine	2015
Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL). Bone marrow transplantation, 2015, Volume: 50, Issue:12 Topics: Adolescent; Adult; Allografts; Busulfan; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation Conditioning	2015
A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee). Pediatric blood & cancer, 2016, Volume: 63, Issue:2 Topics: Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Asparaginase; Child; Child, Preschool; Clofarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Mitoxantrone; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Young Adult	2016
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia. Leukemia research, 2015, Volume: 39, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Cell Activating Factor; Bone Marrow; Chemokine CXCL12; Drug Resistance, Neoplasm; Etoposide; Female; Filgrastim; Gene Expression Regulation, Leukemic; Humans; Ifosfamide; Interleukin-7; Male; Mesna; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Osteocalcin; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Niche; Tumor Microenvironment; Young Adult	2015
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Pediatric blood & cancer, 2009, Volume: 52, Issue:2 Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult	2009
DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study. European journal of haematology, 2009, Dec-01, Volume: 83, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Early Termination of Clinical Trials; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Idarubicin; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Treatment Failure; Vincristine; Young Adult	2009
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia, 2009, Volume: 23, Issue:12 Topics: Acute Disease; Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Treatment Outcome; Young Adult	2009
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia. British journal of haematology, 2009, Volume: 147, Issue:3 Topics: Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome	2009
Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group. Pediatric blood & cancer, 2010, Volume: 54, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Child, Preschool; Cyclosporins; Drug Resistance, Multiple; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Young Adult	2010
Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, May-10, Volume: 28, Issue:14 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Child; Child, Preschool; Cranial Irradiation; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Europe; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Radiotherapy, Adjuvant; Recurrence; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Treatment Outcome	2010
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet (London, England), 2010, Dec-11, Volume: 376, Issue:9757 Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Assessment; Treatment Outcome; United Kingdom; Vidarabine; Vincristine	2010
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Blood, 2011, Dec-01, Volume: 118, Issue:23 Topics: Adenine Nucleotides; Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Nucleoside Transport Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Risk Factors; RNA, Messenger; Young Adult	2011
Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients. Leukemia & lymphoma, 2012, Volume: 53, Issue:9 Topics: Acute Disease; Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Diseases; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Recurrence; Remission Induction; Treatment Outcome	2012
Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation. International journal of radiation oncology, biology, physics, 2013, Jan-01, Volume: 85, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Liver; Male; Middle Aged; Organs at Risk; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Recurrence; Stomatitis; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult	2013
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation. British journal of haematology, 2012, Volume: 159, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Imatinib Mesylate; Male; Mercaptopurine; Methotrexate; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Vincristine; Young Adult	2012
A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia. Leukemia research, 2003, Volume: 27, Issue:1 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Chemical and Drug Induced Liver Injury; DNA Topoisomerases, Type II; Drug Administration Schedule; Drug Resistance, Neoplasm; Enzyme Induction; Enzyme Inhibitors; Etoposide; Female; Gastrointestinal Diseases; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan	2003
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment. Blood, 2003, May-15, Volume: 101, Issue:10 Topics: Adolescent; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Infant; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Placebos; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2003
Pharmacokinetics and pharmacodynamics of oral etoposide in children with relapsed or refractory acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-01, Volume: 21, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Asparaginase; Child; Child, Preschool; Dexamethasone; Etoposide; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine	2003
The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia. Leukemia & lymphoma, 2003, Volume: 44, Issue:3 Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Methotrexate; Methylprednisolone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine	2003
Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells. Leukemia, 2003, Volume: 17, Issue:11 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Child; Cytarabine; Etoposide; fas Receptor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukocyte Count; Leukocytes, Mononuclear; Lymphocyte Depletion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome	2003
Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia. The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:2 Topics: Adolescent; Adult; Amsacrine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Salvage Therapy; Survival Analysis; Treatment Outcome	2004
Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Humans; Idarubicin; Middle Aged; Mouth Mucosa; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome	2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood, 2004, Nov-01, Volume: 104, Issue:9 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cranial Irradiation; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Infant; Injections, Spinal; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Risk Assessment; Treatment Outcome	2004
Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse. Leukemia, 2004, Volume: 18, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Neoplasm Recurrence, Local; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome; Vincristine	2004
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse. Pediatric blood & cancer, 2004, Volume: 43, Issue:5 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Bone Marrow Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Etoposide; Female; Flow Cytometry; Humans; Idarubicin; Ifosfamide; Infant; Infusions, Intravenous; Leucovorin; Male; Mesna; Methotrexate; Mouth Mucosa; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis; Thioguanine; Treatment Outcome; Vincristine	2004
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia, 2005, Volume: 19, Issue:6 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Transplantation, Autologous	2005
Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:10 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diarrhea; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Vomiting, Anticipatory	2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine	2005
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:4 Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Siblings; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2006
Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004. Cancer science, 2007, Volume: 98, Issue:9 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation, Autologous	2007
[Peripheral blood stem cell collection with high dose etoposide]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:3 Topics: Adult; Aged; Blood Component Removal; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Carmustine; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Transplantation, Autologous; Vincristine	1995
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia, 1995, Volume: 9, Issue:10 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Synergism; Etoposide; Humans; Infant; Karyotyping; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone	1995
Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia. American journal of clinical oncology, 1995, Volume: 18, Issue:5 Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy	1995
Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers. British journal of cancer, 1995, Volume: 71, Issue:4 Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasms; Neuroblastoma; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Rhabdomyosarcoma; Sarcoma, Ewing; Verapamil; Wilms Tumor	1995
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors	1995
High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma. Annals of hematology, 1995, Volume: 70, Issue:2 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Time Factors; Vincristine	1995
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Transplantation, Homologous	1995
Comparative analysis of engraftment after cryopreservation of peripheral blood stem cell autografts by controlled- versus uncontrolled-rate methods. Bone marrow transplantation, 1994, Volume: 13, Issue:6 Topics: Adolescent; Blood Transfusion, Autologous; Child; Child, Preschool; Combined Modality Therapy; Cryopreservation; Cyclophosphamide; Cytarabine; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Whole-Body Irradiation	1994
Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia, 1994, Volume: 8, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Survival Analysis; Transplantation, Autologous	1994
Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia. Bone marrow transplantation, 1993, Volume: 12, Issue:6 Topics: Adolescent; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Factors; Transplantation, Autologous; Whole-Body Irradiation	1993
Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study. Cancer, 1993, Sep-01, Volume: 72, Issue:5 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Child; Drug Tolerance; Etoposide; Humans; Ifosfamide; Leukemia, Myeloid; Mesna; Neoplasm Recurrence, Local; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Urinary Tract	1993
Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia. American journal of hematology, 1993, Volume: 43, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy	1993
A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia. Leukemia, 1993, Volume: 7, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1993
Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia. Acta haematologica Polonica, 1995, Volume: 26, Issue:4 Topics: Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Whole-Body Irradiation	1995
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group. Blood, 1996, Apr-15, Volume: 87, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine	1996
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood, 1996, Jun-15, Volume: 87, Issue:12 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Humans; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm, Residual; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Survival Analysis; Treatment Outcome; Vincristine	1996
The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia. Experimental hematology, 1996, Volume: 24, Issue:10 Topics: Adolescent; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Glucocorticoids; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1996
Addition of etoposide to initial therapy of adult acute lymphoblastic leukemia: a combined clinical and laboratory study. Leukemia & lymphoma, 1996, Volume: 23, Issue:1-2 Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Remission Induction; Tumor Cells, Cultured	1996
Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot study. Leukemia & lymphoma, 1996, Volume: 23, Issue:1-2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitoxantrone; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Salvage Therapy	1996
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:2 Topics: Adolescent; Adult; Amsacrine; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitoxantrone; Netherlands; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome	1997
Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. British journal of clinical pharmacology, 1997, Volume: 44, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Dexamethasone; Erythrocytes; Etoposide; Female; Humans; Male; Mercaptopurine; Methotrexate; Methyltransferases; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine; Vincristine	1997
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin. Leukemia, 1998, Volume: 12, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine	1998
[EPOCH therapy for relapsed/refractory lymphoid malignancies]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine	1998
[Preliminary treatment results of relapsed or refractory acute leukemia using two and three drug regimens]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51, Issue:1-2 Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Idarubicin; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction	1998
Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia. Leukemia, 1998, Volume: 12, Issue:7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Thioguanine; Vincristine	1998
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:11 Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine	1998
Effects of G-CSF and high-dose methylprednisolone on peripheral stem cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study. Leukemia research, 2000, Volume: 24, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Interleukin-3; Methotrexate; Methylprednisolone; Neutropenia; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine	2000
Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia. Leukemia, 2000, Volume: 14, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infections; Male; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Risk; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine	2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vincristine	2000
Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia. Medical and pediatric oncology, 2000, Volume: 34, Issue:5 Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Central Nervous System Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Injections, Spinal; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine	2000
Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome. Journal of clinical pathology, 2001, Volume: 54, Issue:1 Topics: Adolescent; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Inhibitors; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Infant; Infant, Newborn; Isoenzymes; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Survival Rate; Topoisomerase II Inhibitors; Treatment Outcome	2001
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. British journal of haematology, 2001, Volume: 113, Issue:1 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Humans; Infant; Leukocyte Count; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Risk Factors; Sex Factors; Thioguanine; United Kingdom; Vincristine	2001
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 2001, Jun-01, Volume: 97, Issue:11 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Rate; Vincristine	2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. Leukemia, 2001, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Injections, Intravenous; Life Tables; Male; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine	2001
The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:6 Topics: Adolescent; Antifungal Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Atovaquone; Child; Child, Preschool; Cross-Over Studies; Drug Interactions; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Naphthoquinones; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trimethoprim, Sulfamethoxazole Drug Combination	2001
Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors. Medical and pediatric oncology, 2001, Volume: 37, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunophenotyping; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Risk; Risk Factors; Severity of Illness Index; Sex Factors; Survival Analysis; Treatment Outcome; Vincristine	2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine	2001
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia. Leukemia, 2002, Volume: 16, Issue:4 Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2002
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood, 1991, Nov-15, Volume: 78, Issue:10 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation	1991
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. The New England journal of medicine, 1991, Dec-12, Volume: 325, Issue:24 Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide	1991
Treatment of relapsed acute lymphocytic leukemia in adults. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine	1990
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:6 Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Vincristine	1990
Treatment of pediatric malignant tumors with VP-16. West Japan Pediatric Oncology Group. Acta paediatrica Japonica : Overseas edition, 1990, Volume: 32, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Histiocytosis; Humans; Infant; Leukemia, Myeloid, Acute; Lymphoma; Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1990
Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias. Bone marrow transplantation, 1989, Volume: 4 Suppl 4 Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Whole-Body Irradiation	1989

Other Studies

182 other study(ies) available for etoposide and Acute Lymphoid Leukemia

Article	Year
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Cytotherapy, 2022, Volume: 24, Issue:9 Topics: Acute Disease; Adult; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm, Residual; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation	2022
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report. Acta haematologica, 2022, Volume: 145, Issue:5 Topics: Acute Disease; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Organophosphorus Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Antigen, T-Cell	2022
Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience. Leukemia research, 2022, Volume: 121 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Humans; Mercaptopurine; Methotrexate; Outpatients; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine	2022
Expression and Clinical Significance of circRNA Changes in Stored Erythrocytes During Platelet Transfusion in Acute Lymphoblastic Leukemia. Clinical laboratory, 2023, Aug-01, Volume: 69, Issue:8 Topics: Clinical Relevance; Etoposide; Humans; Ifosfamide; MicroRNAs; Platelet Transfusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA; RNA, Circular; Splenomegaly	2023
Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia. Pediatric blood & cancer, 2020, Volume: 67, Issue:4 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clofarabine; Cyclophosphamide; Etoposide; Humans; Mice; Precision Medicine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Xenograft Model Antitumor Assays	2020
T Regulatory Cell Frequency During Maintenance Phase Chemotherapy for Pediatric Acute Lymphoblastic Leukemia. Iranian journal of immunology : IJI, 2020, Volume: 17, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Hydrocortisone; Maintenance Chemotherapy; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes, Regulatory; Vincristine	2020
Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients. Annals of hematology, 2021, Volume: 100, Issue:3 Topics: Adolescent; Adult; Age of Onset; Aged; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Child; Child, Preschool; Cohort Studies; Cytarabine; Daunorubicin; Egypt; Etoposide; Female; Humans; Incidence; Induction Chemotherapy; Infant; Leukemia, Biphenotypic, Acute; Maintenance Chemotherapy; Male; Middle Aged; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Treatment Outcome; Young Adult	2021
Comparison of Total Body Irradiation-based Versus Chemotherapy-based Conditionings for Early Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Children With ALL. Journal of pediatric hematology/oncology, 2021, Oct-01, Volume: 43, Issue:7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Organophosphorus Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation	2021
Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis. Annals of hematology, 2021, Volume: 100, Issue:11 Topics: Adolescent; Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Transplantation Conditioning; Vincristine; Young Adult	2021
Unexpected acute renal injury after high-dose etoposide phosphate and total body irradiation in children undergoing hematopoietic stem cell transplantation. Pediatric blood & cancer, 2017, Volume: 64, Issue:12 Topics: Acute Kidney Injury; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Organophosphorus Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Whole-Body Irradiation	2017
Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society American journal of hematology, 2018, Volume: 93, Issue:6 Topics: Adult; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2018
[Establishment of Drug-resistant Acute Lymphoblastic Leukemic Cell Lines and Their Resistance Mechanism]. Zhongguo shi yan xue ye xue za zhi, 2018, Volume: 26, Issue:3 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2018
A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. European journal of cancer (Oxford, England : 1990), 2019, Volume: 113 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Cohort Studies; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Teratoma; Treatment Outcome; Young Adult	2019
[Experimental study of remaxol as a drug for supportive therapy in traditional and high-dose treatment of tumors]. Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; Etoposide; Gemcitabine; Methotrexate; Mice; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Succinates	2013
Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma. Leukemia & lymphoma, 2014, Volume: 55, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome	2014
A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD). Bone marrow transplantation, 2014, Volume: 49, Issue:3 Topics: Adenine Nucleotides; Adolescent; Antimetabolites, Antineoplastic; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Probability; Remission Induction; Time Factors; Treatment Outcome; Young Adult	2014
Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party. Acta haematologica, 2015, Volume: 133, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult	2015
Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:1 Topics: Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Injections, Intravenous; Male; Myeloablative Agonists; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine; Young Adult	2015
Clofarabine-based combination chemotherapy for relapse and refractory childhood acute lymphoblastic leukemia. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:11 Topics: Adenine Nucleotides; Adolescent; Analgesics, Opioid; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Cefazolin; Child; Clofarabine; Cyclophosphamide; Etoposide; Fentanyl; Humans; Induction Chemotherapy; Male; Pain; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Shock, Septic; Systemic Inflammatory Response Syndrome; Treatment Outcome	2014
Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse. Archivum immunologiae et therapiae experimentalis, 2015, Volume: 63, Issue:5 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cell Proliferation; Cells, Cultured; Child; Disease-Free Survival; Drug Dosage Calculations; Etoposide; Female; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; In Vitro Techniques; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk; T-Lymphocytes, Cytotoxic; Th1-Th2 Balance; Transplantation, Homologous	2015
Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo. Scientific reports, 2015, Jul-20, Volume: 5 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Glycolipids; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Topoisomerase I Inhibitors; Tumor Suppressor Protein p53	2015
Refractory acute lymphoblastic leukemia in Chinese children: bridging to stem cell transplantation with clofarabine, cyclophosphamide and etoposide. Annals of hematology, 2016, Volume: 95, Issue:3 Topics: Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Asian People; Child; Child, Preschool; Clofarabine; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Young Adult	2016
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia]. Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Logistic Models; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Multivariate Analysis; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine	2016
Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia. Leukemia & lymphoma, 2016, Volume: 57, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retreatment; Treatment Outcome; Young Adult	2016
Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair. Oncotarget, 2016, May-24, Volume: 7, Issue:21 Topics: Cell Cycle Checkpoints; Comet Assay; DNA Breaks, Double-Stranded; DNA Damage; DNA End-Joining Repair; Etoposide; Gene Expression; HEK293 Cells; Histones; Homologous Recombination; Humans; Infant; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation, Ionizing	2016
Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association. Pediatric blood & cancer, 2016, Volume: 63, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Treatment Failure; Vincristine; Viral Load	2016
Development of a Limited Sampling Strategy for the Estimation of Exposure to High-Dose Etoposide After Intravenous Infusion in Pediatric Patients. Therapeutic drug monitoring, 2017, Volume: 39, Issue:2 Topics: Adolescent; Area Under Curve; Child; Drug Monitoring; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Specimen Handling; Transplantation Conditioning	2017
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. Blood, 2008, Aug-01, Volume: 112, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Child; Child, Preschool; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Risk Factors; Siblings; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation	2008
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia. Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:7 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Charcot-Marie-Tooth Disease; Contraindications; Cytarabine; Daunorubicin; Etoposide; Gait Disorders, Neurologic; Humans; Male; Mercaptopurine; Methotrexate; Muscle Weakness; Neural Conduction; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine	2008
PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells. The Journal of biological chemistry, 2008, Dec-19, Volume: 283, Issue:51 Topics: Amino Acid Substitution; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; eIF-2 Kinase; Etoposide; Eukaryotic Initiation Factor-2B; Humans; Mutation, Missense; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction	2008
Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors. Mutagenesis, 2009, Volume: 24, Issue:2 Topics: Adolescent; Adult; Base Sequence; Case-Control Studies; Child; Child, Preschool; Chromosomes, Human, Pair 11; Cytogenetic Analysis; Etoposide; Gene Rearrangement; Humans; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survivors; Teniposide; Translocation, Genetic	2009
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA, 2009, Jan-28, Volume: 301, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Flow Cytometry; Follow-Up Studies; Genotype; Germ-Line Mutation; Humans; Infant; Linear Models; Linkage Disequilibrium; Male; Methotrexate; Neoplasm, Residual; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Retrospective Studies; Risk Assessment; Risk Factors	2009
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia, 2009, Volume: 23, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; T-Lymphocytes; Treatment Outcome; Vincristine	2009
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy. Annals of hematology, 2009, Volume: 88, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Salvage Therapy; Vincristine; Vindesine; Young Adult	2009
The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells. Mutagenesis, 2009, Volume: 24, Issue:4 Topics: Benzene; Cell Line, Tumor; Chromosomes; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Genomics; Humans; Hydroquinones; Lymphocytes; Metaphase; Mutagenicity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Topoisomerase II Inhibitors	2009
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. Acta pharmacologica Sinica, 2009, Volume: 30, Issue:10 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Idarubicin; Immunosuppressive Agents; Leukemia; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Mucositis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Retrospective Studies; Risk Factors; Semustine; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation	2009
A case of Langerhans cell histiocytosis in an adult with initial symptoms confined to the skin. International journal of dermatology, 2010, Volume: 49, Issue:3 Topics: Dexamethasone; Etoposide; Fatal Outcome; Histiocytosis, Langerhans-Cell; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Diseases; Vinblastine; Young Adult	2010
Pharmacokinetics of high-dose etoposide administered in combination with fractionated total-body irradiation as conditioning for allogeneic hematopoietic stem cell transplantation in children with acute lymphoblastic leukemia. Pediatric transplantation, 2011, Volume: 15, Issue:1 Topics: Adolescent; Antineoplastic Agents; Area Under Curve; Child; Child, Preschool; Chromatography, High Pressure Liquid; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2011
Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia. International journal of hematology, 2011, Volume: 94, Issue:5 Topics: Adolescent; Adult; Cyclophosphamide; Etoposide; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation; Young Adult	2011
MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance. Journal of experimental & clinical cancer research : CR, 2011, Dec-20, Volume: 30 Topics: Amino Acid Sequence; Base Sequence; Cell Growth Processes; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Leukemic; Homeodomain Proteins; Humans; Jurkat Cells; Molecular Sequence Data; Myeloid Ecotropic Viral Integration Site 1 Protein; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Messenger; Transcription Factors; Transcriptional Activation; Up-Regulation	2011
Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience. American journal of hematology, 2012, Volume: 87, Issue:6 Topics: Adenine Nucleotides; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Cyclophosphamide; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Off-Label Use; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Salvage Therapy; Spain; Young Adult	2012
Orbital plasmablastic lymphoma with remission following chemotherapy. Journal of radiology case reports, 2011, Volume: 5, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Multimodal Imaging; Orbital Neoplasms; Polyethylene Glycols; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recombinant Proteins; Remission Induction; Tomography, X-Ray Computed; Vincristine	2011
Probable cytarabine-induced acral erythema: report of 2 pediatric cases. Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis	2013
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B. Cell death & disease, 2012, Aug-09, Volume: 3 Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-X Protein; Biphenyl Compounds; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Humans; Minor Histocompatibility Antigens; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Sulfonamides; T-Lymphocytes; Tumor Suppressor Protein p53	2012
Identification of the genes expression profile associated with the ex vivo resistance to etoposide in childhood acute leukemias. Postepy higieny i medycyny doswiadczalnej (Online), 2012, Jun-19, Volume: 66 Topics: Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents, Phytogenic; Child; Cleavage And Polyadenylation Specificity Factor; Drug Resistance, Neoplasm; Etoposide; Gene Expression Profiling; Growth Hormone; Humans; In Vitro Techniques; Oligonucleotide Array Sequence Analysis; Placental Hormones; Precursor Cell Lymphoblastic Leukemia-Lymphoma; rho GTP-Binding Proteins; Transcription Factors; Transcriptome	2012
Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia. Anticancer research, 2012, Volume: 32, Issue:12 Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Infant; Male; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Vincristine	2012
CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside. Acta haematologica, 2002, Volume: 108, Issue:1 Topics: Acute Disease; Aged; Antigens, CD; Antigens, CD7; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Cytarabine; Daunorubicin; Diagnosis, Differential; Etoposide; Fatal Outcome; Humans; Idarubicin; Killer Cells, Natural; Leukemia, Myeloid; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Mitoxantrone; Myeloid Cells; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Myeloid; Sialic Acid Binding Ig-like Lectin 3	2002
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia. Bone marrow transplantation, 2002, Volume: 30, Issue:12 Topics: Adult; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Betamethasone; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Humans; Imatinib Mesylate; Immunosuppressive Agents; Mitoxantrone; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Homologous; Vincristine	2002
Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia. Leukemia research, 2003, Volume: 27, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dental Enamel Hypoplasia; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Odontogenesis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Teniposide; Tooth Abnormalities; Tooth Diseases; Tooth Eruption; Tooth Root; Vincristine	2003
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes, chromosomes & cancer, 2003, Volume: 36, Issue:4 Topics: Acute Disease; Adolescent; Amino Acid Sequence; Child; Child, Preschool; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; DNA-Binding Proteins; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myeloid; Male; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Nuclear Proteins; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Transcription Factors; Tumor Cells, Cultured	2003
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation. Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Burkitt Lymphoma; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Humans; Immunotherapy; Leukemic Infiltration; Male; Meninges; Methotrexate; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Testis; Topotecan; Transplantation, Autologous; Vindesine	2003
[De novo acute lymphocytic leukemia with t(14;18) complicated by tumor lysis syndrome]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, May-10, Volume: 92, Issue:5 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Fatal Outcome; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Rituximab; Translocation, Genetic; Treatment Failure; Tumor Lysis Syndrome; Vincristine	2003
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood, 2004, Jan-01, Volume: 103, Issue:1 Topics: Base Sequence; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Neoplasm; Etoposide; Female; Genes, MDR; Genotype; Glucuronosyltransferase; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Receptors, Calcitriol	2004
Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience. Experimental hematology, 2003, Volume: 31, Issue:10 Topics: Adolescent; Adult; Child; Child, Preschool; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Rate; Transplantation, Homologous; Treatment Failure; Whole-Body Irradiation	2003
PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation. Leukemia, 2004, Volume: 18, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Benzopyrans; Cell Cycle; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitriles; Phosphoprotein Phosphatases; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase C; Protein Kinase C-alpha; Protein Phosphatase 2; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured	2004
Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt. Leukemia research, 2004, Volume: 28, Issue:7 Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Cell Survival; Coculture Techniques; Cytarabine; Etoposide; Humans; Mice; Phosphoprotein Phosphatases; Phosphorylation; Poly(ADP-ribose) Polymerases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Stromal Cells	2004
High-dose cytosine arabinoside and etoposide with total body irradiation as a preparatory regimen for allogeneic hematopoietic stem-cell transplantation in patients with acute lymphoblastic leukemia. Bone marrow transplantation, 2004, Volume: 34, Issue:4 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cytarabine; Etoposide; Female; Humans; Immunosuppressive Agents; Living Donors; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Siblings; Stem Cell Transplantation; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation	2004
Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. Blood, 2004, Oct-15, Volume: 104, Issue:8 Topics: Adolescent; Cell Line, Tumor; Child; Child, Preschool; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 21; Core Binding Factor Alpha 2 Subunit; Diploidy; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; ETS Translocation Variant 6 Protein; Female; Gene Order; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; Repressor Proteins; Transcription Factors; Translocation, Genetic	2004
Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma. Leukemia & lymphoma, 2004, Volume: 45, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome	2004
Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study. Bone marrow transplantation, 2005, Volume: 36, Issue:2 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Idarubicin; Leukocyte Transfusion; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Recurrence; Tissue Donors; Transplantation, Homologous; Treatment Outcome	2005
Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1. International journal of oncology, 2005, Volume: 27, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Antibodies, Monoclonal; Antigens, CD19; Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; Blotting, Western; Caspase 3; Caspase 8; Caspases; Cell Line, Tumor; Child; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; fas Receptor; Fas-Associated Death Domain Protein; Flow Cytometry; Humans; Lewis X Antigen; Mutation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding	2005
Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Nov-01, Volume: 23, Issue:31 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Risk Factors; Survival Rate; Teniposide	2005
TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease. Leukemia & lymphoma, 2005, Volume: 46, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Chromosome Mapping; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 21; Cytarabine; Etoposide; Exons; Humans; Idarubicin; Infant; Male; Neoplasm, Residual; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA-Binding Protein FUS; Translocation, Genetic; Treatment Outcome	2005
Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. Haematologica, 2005, Volume: 90, Issue:12 Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Drug Evaluation; Drug Synergism; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Infant; Leukemia-Lymphoma, Adult T-Cell; Male; Methylprednisolone; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recombinant Proteins; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thiotepa; Topotecan; Treatment Outcome; Vidarabine; Vinblastine	2005
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatric blood & cancer, 2007, Volume: 48, Issue:3 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Male; Mercaptopurine; Methotrexate; Patient Selection; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Research Design; Survival Analysis; Thioguanine; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vincristine	2007
Role of chemotherapy resistance genes in outcome of neuroblastoma. Pediatric blood & cancer, 2007, Volume: 48, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cell Line, Tumor; Child; Child, Preschool; Chromosome Deletion; Chromosomes, Human, Pair 1; Cisplatin; Computer Systems; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Profiling; Genes, MDR; Genes, myc; Humans; Infant; Kaplan-Meier Estimate; Male; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; S Phase; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine	2007
Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia. Haematologica, 2006, Volume: 91, Issue:5 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dendritic Cells; Disease Progression; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Kidney; Leukemic Infiltration; Leukocyte Transfusion; Magnetic Resonance Imaging; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Protection; Recurrence; Salvage Therapy; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2006
[Drug sensitivity of tumor cells in varieties of acute childhood leukemia]. Voprosy onkologii, 2005, Volume: 51, Issue:5 Topics: Antigens, CD34; Antineoplastic Agents; Apoptosis; Asparagine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Cells, Cultured; Vincristine	2005
Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia. Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Abscess; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Daunorubicin; Dexamethasone; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Liposomes; Lung Diseases, Fungal; Mercaptopurine; Mitoxantrone; Mucormycosis; Pneumonia, Viral; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Transplantation, Homologous; Vincristine	2006
[Twenty years of treating childhood acute lymphoblastic leukemia]. Anales de pediatria (Barcelona, Spain : 2003), 2006, Volume: 65, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Recurrence; Risk Factors; Survival Rate; Time Factors; Vincristine	2006
Etoposide pharmacokinetics in children treated for acute myeloid leukemia. Anti-cancer drugs, 2006, Volume: 17, Issue:9 Topics: Adolescent; Alanine Transaminase; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Down Syndrome; Etoposide; Female; Humans; Infant; Male; Metabolic Clearance Rate; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2006
Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens. Bone marrow transplantation, 2006, Volume: 38, Issue:11 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation	2006
Diverse pathways mediate chemotherapy-induced cell death in acute lymphoblastic leukemia cell lines. Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 8; Cell Line, Tumor; Etoposide; Humans; Mitochondria; NF-kappa B; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Suppressor Protein p53	2006
Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Etoposide; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Skin; Sunburn; Ultraviolet Rays; Whole-Body Irradiation	2007
Conditioning regimens for acute lymphoblastic leukaemia allografts. Bone marrow transplantation, 2007, Volume: 39, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Etoposide; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2007
A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia. British journal of haematology, 2007, Volume: 138, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Tumor Burden	2007
In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Sep-15, Volume: 13, Issue:18 Pt 2 Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Autoantigens; Combined Modality Therapy; Cyclophosphamide; DNA Damage; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Immunoblotting; Immunoconjugates; Indium Radioisotopes; Lymphoma, T-Cell; Mice; Mice, Inbred C57BL; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioimmunotherapy; Ribonucleoproteins; SS-B Antigen; Thymus Gland; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2007
Lipomembranous panniculitis in a patient with acute leukemia induced by chemotherapy. Leukemia research, 2008, Volume: 32, Issue:4 Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Fat Necrosis; Female; Humans; Methotrexate; Panniculitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2008
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2008, Volume: 14, Issue:5 Topics: Adolescent; Adult; Cyclophosphamide; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation	2008
Calla positive acute lymphoblastic leukemia after etoposide-based therapy for Ewing's sarcoma. Leukemia research, 1995, Volume: 19, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Humans; Male; Neoplasms, Second Primary; Neprilysin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Ewing; Tibia	1995
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood, 1993, Dec-15, Volume: 82, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Length of Stay; Leukapheresis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Vincristine	1993
Lymphoma-associated pancreatitis as a presenting manifestation of immunoblastic lymphoma. Leukemia & lymphoma, 1994, Volume: 12, Issue:3-4 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Humans; Lymph Nodes; Lymphoma, B-Cell; Male; Middle Aged; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Tomography, X-Ray Computed; Vincristine	1994
Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Bone marrow transplantation, 1995, Volume: 15, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukapheresis; Lymphocyte Count; Lymphocyte Subsets; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Mesna; Middle Aged; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Treatment Outcome; Vincristine	1995
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. Bone marrow transplantation, 1995, Volume: 15, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Transplantation, Autologous; Treatment Outcome	1995
Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts. Blood, 1993, Feb-01, Volume: 81, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Cytarabine; Daunorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Non-Hodgkin; Macrophage Colony-Stimulating Factor; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Time Factors; Transplantation, Autologous	1993
[Peripheral blood stem cell transplantation in adult patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:4 Topics: Adolescent; Adult; Blood Cell Count; Cell Separation; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1993
[High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1993, Volume: 15, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine; Whole-Body Irradiation	1993
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup. Leukemia & lymphoma, 1993, Volume: 10, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Survival Analysis; Vincristine	1993
Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. European journal of pharmacology, 1994, Dec-15, Volume: 288, Issue:1 Topics: Allosteric Regulation; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cell Division; Cyclosporine; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Kinetics; Mathematics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tritium; Tumor Cells, Cultured; Vinblastine; Vincristine	1994
Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia. The Annals of pharmacotherapy, 1995, Volume: 29, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Infusions, Intravenous; Male; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index; Vomiting	1995
Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia. Journal of pediatric hematology/oncology, 1995, Volume: 17, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Mesna; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence	1995
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood, 1995, Jun-01, Volume: 85, Issue:11 Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation	1995
Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. Cancer research, 1995, Jan-01, Volume: 55, Issue:1 Topics: Antineoplastic Agents; Cell Cycle; Cell Division; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured	1995
Distinct MLL gene rearrangements associated with successive acute monocytic and lymphoblastic leukemias in the same patient. Leukemia, 1994, Volume: 8, Issue:12 Topics: Adult; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Chromosomes, Human, Pair 6; Etoposide; Gene Rearrangement; Humans; In Situ Hybridization, Fluorescence; Leukemia, Monocytic, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic	1994
Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone marrow transplantation, 1994, Volume: 13, Issue:4 Topics: Acute Disease; Adolescent; Adult; Blood Component Transfusion; Busulfan; Combined Modality Therapy; Etoposide; Female; Flow Cytometry; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Lymphocyte Subsets; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1994
Allogeneic bone marrow transplantation following busulfan-cyclophosphamide with or without etoposide conditioning regimen for patients with acute lymphoblastic leukaemia. British journal of haematology, 1993, Volume: 85, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Recurrence; Transplantation, Homologous	1993
Intensive conditioning regimen for bone marrow transplantation in children with high-risk haematological malignancies. Medical and pediatric oncology, 1994, Volume: 23, Issue:6 Topics: Adolescent; Bacterial Infections; Bone Marrow Transplantation; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Humans; Infant; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Remission Induction; Stomatitis; Survival Rate; Whole-Body Irradiation	1994
Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs. Leukemia & lymphoma, 1994, Volume: 13, Issue:1-2 Topics: Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Phospholipid Ethers; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Analysis; Whole-Body Irradiation	1994
Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide. Transplantation proceedings, 1994, Volume: 26, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Etoposide; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Whole-Body Irradiation	1994
Langerhans cell histiocytosis and etoposide: risks vs. benefits. Medical and pediatric oncology, 1994, Volume: 23, Issue:2 Topics: Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors	1994
Acute leukemia in association with Langerhans cell histiocytosis. Medical and pediatric oncology, 1994, Volume: 23, Issue:2 Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Retrospective Studies; Surveys and Questionnaires; Vinblastine; Vincristine	1994
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood, 1993, Nov-01, Volume: 82, Issue:9 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Etoposide; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Whole-Body Irradiation	1993
Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: failure to detect evidence of apoptosis in vivo. European journal of haematology, 1994, Volume: 52, Issue:1 Topics: Adolescent; Apoptosis; Child; Child, Preschool; DNA Damage; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Cells, Cultured	1994
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous	1993
Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia. Cancer research, 1993, Jul-01, Volume: 53, Issue:13 Topics: Child, Preschool; Chromosomes, Human, Pair 11; DNA-Cytosine Methylases; DNA, Neoplasm; Etoposide; Humans; Leukemia, Monocytic, Acute; Male; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic	1993
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer research, 1993, Sep-01, Volume: 53, Issue:17 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Etoposide; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Molecular Weight; NAD; Peptide Fragments; Poly(ADP-ribose) Polymerases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protease Inhibitors	1993
Changes in the oral microflora during cytotoxic chemotherapy in children being treated for acute leukemia. Oral surgery, oral medicine, and oral pathology, 1993, Volume: 76, Issue:2 Topics: Adolescent; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Candida albicans; Candidiasis, Oral; Chi-Square Distribution; Child; Child, Preschool; Chlorhexidine; Colony Count, Microbial; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Mouth; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Streptococcus mutans; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine	1993
Dipyridamole enhancement of drug sensitivity in acute lymphoblastic leukemia cells. American journal of hematology, 1993, Volume: 43, Issue:4 Topics: Administration, Oral; Antineoplastic Agents; Bone Marrow; Child; Dipyridamole; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Synergism; Etoposide; Female; Humans; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vincristine	1993
24-hour plasma etoposide profile after oral and intravenous administration in children. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:10 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Etoposide; Humans; Injections, Intravenous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Soft Tissue Neoplasms; Time Factors	1993
Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation. Cancer research, 1993, Oct-15, Volume: 53, Issue:20 Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Metabolic Clearance Rate; Neoplasms; Neuroblastoma; Pineal Gland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Soft Tissue Neoplasms; Teratoma	1993
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:2 Topics: Acute Disease; Adolescent; Bone Marrow; Burkitt Lymphoma; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk; Treatment Outcome	1993
Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2 Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Child; Etoposide; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction	1996
True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood, 1996, Jun-15, Volume: 87, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine	1996
A T cell lymphoblastic lymphoma patient with two malignant cell populations carrying different 9p deletions including the p16INK4 and p15INK4B genes: Clinical response to interferon-alpha therapy in one of the subclones. Leukemia, 1996, Volume: 10, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Cycle Proteins; Chromosome Deletion; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Deletion; Humans; Immunologic Factors; Interferon-alpha; Male; Neoplasm Proteins; Neoplastic Stem Cells; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; Tumor Suppressor Proteins; Vincristine	1996
[Paraplegia following intrathecal chemotherapy]. Schweizerische medizinische Wochenschrift, 1996, Jun-22, Volume: 126, Issue:25 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Etoposide; Humans; Injections, Spinal; Male; Paraplegia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone	1996
Higher in vivo protein binding of etoposide in children compared with adult cancer patients. Cancer letters, 1996, Aug-23, Volume: 106, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Child; Child, Preschool; Etoposide; Female; Histiocytic Sarcoma; Humans; Infant; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Oligodendroglioma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Reference Values; Serum Albumin	1996
Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:10 Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence	1996
Method for quantifying expression of functionally active topoisomerase II in patients with leukaemia. Journal of clinical pathology, 1996, Volume: 49, Issue:10 Topics: Adolescent; Adult; Aged; Animals; Biochemistry; Blastomeres; Crithidia fasciculata; DNA Topoisomerases, Type II; DNA, Kinetoplast; Doxorubicin; Ellipticines; Ethylmaleimide; Etoposide; Female; Humans; Male; Middle Aged; Novobiocin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Sensitivity and Specificity; Topoisomerase II Inhibitors	1996
11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone. American journal of hematology, 1996, Volume: 53, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 11; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Humans; Karyotyping; Leukemia, Monocytic, Acute; Mitoxantrone; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Topoisomerase II Inhibitors	1996
Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicity. Biochemistry, 1996, Dec-17, Volume: 35, Issue:50 Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line; Cell Survival; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Humans; Isoenzymes; Kinetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Tumor Cells, Cultured	1996
Testicular morphological changes in children with acute lymphoblastic leukemia following chemotherapy. Acta paediatrica Japonica : Overseas edition, 1996, Volume: 38, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocortisone; Leydig Cells; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Sertoli Cells; Spermatogonia; Testis	1996
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood, 1997, Apr-15, Volume: 89, Issue:8 Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine	1997
Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents. Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4 Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 11; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Recurrence; Remission Induction; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic	1997
Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia, 1997, Volume: 11, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Topoisomerase II Inhibitors	1997
Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide. Leukemia research, 1997, Volume: 21, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Fever; Gastrointestinal Diseases; Humans; Hydrocortisone; Hydroxyurea; Leucovorin; Male; Methotrexate; Mitoxantrone; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome	1997
Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide. Journal of experimental & clinical cancer research : CR, 1997, Volume: 16, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Child; Cyclosporine; Drug Resistance, Multiple; Etoposide; Female; Growth Inhibitors; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured	1997
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia, 1998, Volume: 12, Issue:3 Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Erythrocytes; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Metabolic Clearance Rate; Methyltransferases; Models, Biological; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Regression Analysis; Serum Albumin; Time Factors	1998
Leukemic cells with 11q23 translocations express granulocyte colony-stimulating factor (G-CSF) receptor and their proliferation is stimulated with G-CSF. Leukemia, 1998, Volume: 12, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Blast Crisis; Cell Division; Cell Line; Chromosome Mapping; Chromosomes, Human, Pair 11; Cytarabine; DNA Replication; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Immunophenotyping; Infant; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Granulocyte Colony-Stimulating Factor; Tumor Cells, Cultured	1998
The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy. Mutation research, 1998, Nov-09, Volume: 419, Issue:1-3 Topics: Base Sequence; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; DNA Nucleotidyltransferases; Etoposide; Humans; Lymphocytes; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic; VDJ Recombinases	1998
High-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in children with high-risk NHL and ALL-preliminary results. Bone marrow transplantation, 1998, Volume: 22 Suppl 4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Cyclosporine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Autologous; Treatment Outcome	1998
Total body irradiation, cyclophosphamide, and etoposide with stem cell transplant as treatment for infants with acute lymphocytic leukemia. Medical and pediatric oncology, 1999, Volume: 32, Issue:1 Topics: Age Factors; Antigens, CD34; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Fetal Blood; Follow-Up Studies; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Infant; Leukocyte Count; Male; Neoplasm Recurrence, Local; Neprilysin; Neutrophils; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation	1999
Early detection by ultrasound scan of severe post-chemotherapy gut complications in patients with acute leukemia. Haematologica, 1999, Volume: 84, Issue:3 Topics: Acute Disease; Adult; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dilatation, Pathologic; Enterocolitis; Etoposide; Female; Gallbladder Diseases; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Intubation, Gastrointestinal; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Ultrasonography	1999
Development of acute lymphoblastic leukemia following hemophagocytic lymphohistiocytosis: is it secondary leukemia? International journal of hematology, 1999, Volume: 70, Issue:1 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cell Transformation, Neoplastic; Child, Preschool; Dexamethasone; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1999
Effects of CSFS and their combinations with chemotherapeutic agents (CH) on leukemic blasts (LB) in children (MTT-assay). Advances in experimental medicine and biology, 1999, Volume: 457 Topics: Adolescent; Adult; Antineoplastic Agents; Blast Crisis; Bone Marrow Cells; Child; Child, Preschool; Colony-Stimulating Factors; Cytarabine; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infant; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1999
Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome? Leukemia, 2000, Volume: 14, Issue:5 Topics: Antineoplastic Agents; Blast Crisis; Cell Survival; Child; Cytarabine; Dexamethasone; Down Syndrome; Doxorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine; Treatment Outcome; Tumor Cells, Cultured	2000
Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation. Biochemical pharmacology, 2000, Sep-15, Volume: 60, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Etoposide; Humans; I-kappa B Proteins; Leupeptins; Multienzyme Complexes; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Endopeptidase Complex; Tumor Cells, Cultured; U937 Cells	2000
Acute lymphoblastic leukemia presenting as acute hepatic failure in childhood. Leukemia & lymphoma, 2000, Volume: 38, Issue:5-6 Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Child; Diagnosis, Differential; Etoposide; Female; Humans; Liver Failure, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone	2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood, 2000, Oct-15, Volume: 96, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Etoposide; Female; Flow Cytometry; Humans; Hydrocortisone; Immunophenotyping; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Neoplastic Cells, Circulating; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vincristine	2000
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. British journal of haematology, 2000, Volume: 110, Issue:4 Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Statistics, Nonparametric; Teniposide; Thioguanine; Vincristine	2000
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission. Bone marrow transplantation, 2000, Volume: 26, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Idarubicin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Whole-Body Irradiation	2000
Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood, 2001, Feb-01, Volume: 97, Issue:3 Topics: Aminophylline; Apoptosis; B-Lymphocytes; Base Sequence; Chromosome Breakage; Chromosome Mapping; Core Binding Factor Alpha 2 Subunit; Culture Media, Serum-Free; Etoposide; Humans; Hydrogen Peroxide; Infant, Newborn; Molecular Sequence Data; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Messenger; Salicylic Acid; Transcription, Genetic; Translocation, Genetic; Tumor Cells, Cultured	2001
Total body irradiation before allogeneic bone marrow transplantation: is more dose better? International journal of radiation oncology, biology, physics, 2001, Mar-15, Volume: 49, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2001
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols. British journal of haematology, 2001, Volume: 112, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, B-Cell; Palliative Care; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Treatment Outcome; Vincristine	2001
Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation. American journal of hematology, 2001, Volume: 67, Issue:3 Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immune System; Immunocompromised Host; Male; Methotrexate; Middle Aged; Opportunistic Infections; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Respiratory Insufficiency; Transplantation Conditioning; Transplantation, Autologous; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine; Whole-Body Irradiation	2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia, 2001, Volume: 15, Issue:6 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, Replacement, Hip; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Femur Head Necrosis; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; Vincristine	2001
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Proceedings of the National Academy of Sciences of the United States of America, 2001, Aug-14, Volume: 98, Issue:17 Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine	2001
Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy. Leukemia research, 2001, Volume: 25, Issue:10 Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Marrow Cells; Caspase 3; Caspases; Cell Survival; Coculture Techniques; Cytarabine; Etoposide; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stromal Cells; Tumor Cells, Cultured	2001
Bioavailability and pharmacokinetic features of etoposide in childhood acute lymphoblastic leukemia patients. Leukemia & lymphoma, 2001, Volume: 42, Issue:3 Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Child; Child, Preschool; Etoposide; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Phytotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2001
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood, 2002, Jan-01, Volume: 99, Issue:1 Topics: Amsacrine; Anthracyclines; Antineoplastic Agents; Busulfan; Cell Survival; Child; Child, Preschool; Cytarabine; Down Syndrome; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Thioguanine; Vincristine	2002
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients. Annals of hematology, 2001, Volume: 80, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mechlorethamine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Taiwan; Treatment Outcome; Vincristine	2001
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration]. Harefuah, 2001, Volume: 140, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation	2001
Diversity of the apoptotic response to chemotherapy in childhood leukemia. Leukemia, 2002, Volume: 16, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspases; Child; Child, Preschool; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; Dexamethasone; Enzyme Induction; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Genes, bcl-2; Genes, p53; Humans; Idarubicin; Infant; Male; Neoplasm Proteins; Neoplastic Stem Cells; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-mdm2; Thioguanine; Tumor Suppressor Protein p53; Vincristine	2002
Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications. Leukemia & lymphoma, 2002, Volume: 43, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Logistic Models; Longitudinal Studies; Male; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Retrospective Studies; Survival Analysis; Tumor Suppressor Protein p53; Vincristine	2002
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, May-15, Volume: 20, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunophenotyping; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Factors; Treatment Outcome; Vincristine	2002
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; France; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Vincristine	2002
Secondary lymphoblastic leukemia following treatment of a malignant germ cell tumour. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testicular Neoplasms	1992
Intrathecal administration of etoposide in the treatment of malignant meningitis: feasibility and pharmacokinetic data. Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:4 Topics: Adult; Carcinoma, Small Cell; Etoposide; Feasibility Studies; Humans; Injections, Spinal; Lung Neoplasms; Male; Meningitis; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1992
Secondary leukaemias after epipodophyllotoxins. Lancet (London, England), 1992, Sep-12, Volume: 340, Issue:8820 Topics: Adult; Child; Etoposide; Humans; Karyotyping; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1992
[Treatment of elderly patients with hematological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:11 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Vincristine	1992
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen. Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Salvage Therapy; Vindesine	1992
Cyclosporin A potentiation of VP-16: production of long-term survival in murine acute lymphatic leukemia. Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:1 Topics: Animals; Cyclosporine; Drug Synergism; Etoposide; Female; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred Strains; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Time Factors	1992
Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation. Bone marrow transplantation, 1992, Volume: 9, Issue:5 Topics: Bone Marrow Transplantation; Busulfan; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Graft vs Host Disease; Hematopoiesis; Humans; Incidence; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1992
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717). Journal of cancer research and clinical oncology, 1991, Volume: 117, Issue:6 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Line; Cisplatin; Cross Reactions; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Folic Acid; Humans; Leucovorin; Membrane Glycoproteins; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; RNA, Messenger; Thymidylate Synthase; Trimetrexate; Vincristine	1991
Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro. Anti-cancer drug design, 1991, Volume: 6, Issue:5 Topics: Animals; Bleomycin; Drug Synergism; Etoposide; Humans; Indomethacin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Lung Neoplasms; Lymphoma; Methotrexate; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostaglandins; Protein Kinase Inhibitors; Tumor Cells, Cultured	1991
Treatment of relapsed or refractory adult acute lymphocytic leukemia. Cancer, 1992, Feb-01, Volume: 69, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Vindesine	1992
Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. Journal of the National Cancer Institute, 1992, Feb-19, Volume: 84, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Infant; Leucovorin; Male; Methotrexate; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1992
Unaltered pharmacokinetics after the administration of high-dose etoposide without prior dilution. Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:3 Topics: Acute Disease; Adolescent; Adult; Biological Availability; Bone Marrow Transplantation; Chromatography, High Pressure Liquid; Combined Modality Therapy; Etoposide; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage	1991
VP16 and TBI as conditioning regimen for allogeneic BMT in patients with high risk and relapsed ALL and NHL. Bone marrow transplantation, 1991, Volume: 7 Suppl 2 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Reoperation; Risk Factors; Whole-Body Irradiation	1991
[Effectiveness of etoposide on reactive histiocytosis and refractory state to platelet transfusion during therapy of leukemia: case report]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1991, Volume: 32, Issue:9 Topics: Blood Component Transfusion; Child; Etoposide; Female; Histiocytosis; Humans; Leukemia, Myeloid, Acute; Platelet Transfusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1991
Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia. Cancer, 1991, Feb-15, Volume: 67, Issue:4 Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bronchial Spasm; Child; Child, Preschool; Cyanosis; Diphenhydramine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Etoposide; Female; Humans; Hypotension; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Teniposide	1991
Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bone marrow transplantation, 1990, Volume: 5, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Preoperative Care; Radiotherapy, High-Energy; Remission Induction; Stomatitis; Whole-Body Irradiation	1990
Development and properties of an etoposide-resistant human leukaemic CCRF-CEM cell line. Anti-cancer drug design, 1990, Volume: 5, Issue:1 Topics: Cell Division; Cell Line; Cell Nucleus; Culture Media; DNA Topoisomerases, Type II; DNA, Circular; DNA, Kinetoplast; DNA, Neoplasm; Drug Resistance; Etoposide; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1990
Successful treatment of acute leukemia with t(4;11) in an infant with congenital hypothyroidism. The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Congenital Hypothyroidism; Cranial Irradiation; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hypothyroidism; Infant; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Translocation, Genetic; Vincristine	1990
Combination chemotherapy and verapamil to purge drug resistant leukemia cells from human bone marrow. Progress in clinical and biological research, 1990, Volume: 333 Topics: Bone Marrow; Bone Marrow Transplantation; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Drug Interactions; Drug Resistance; Etoposide; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Verapamil	1990
Effect of methylprednisolone and VP-16 on acute lymphocytic leukemia cells. Progress in clinical and biological research, 1990, Volume: 333 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Cells; Child; Etoposide; Humans; In Vitro Techniques; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1990
Continuous infusion diaziquone and etoposide: a phase I study in adult patients with acute leukemia. Leukemia, 1990, Volume: 4, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Blast Crisis; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1990
In vitro evaluation of combination drug purging for autologous bone marrow transplantation. Bone marrow transplantation, 1990, Volume: 5, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine	1990
High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission. Cancer, 1990, Aug-15, Volume: 66, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocytes; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate	1990
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy. Cancer, 1990, Aug-15, Volume: 66, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Survival Rate	1990
[Multi-agent combination chemotherapy for adult acute lymphoblastic leukemia--individualized chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Survival Rate; Vindesine	1990
Treatment of refractory acute leukaemia with aclacinomycin A. Bone marrow transplantation, 1989, Volume: 4 Suppl 3 Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1989
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide. Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence	1989